John Evenden, PhD
John Evenden has PhDs in Experimental Psychology from the University of Cambridge, England and Medical Pharmacology from the Uppsala University in Sweden. He did postdoctoral studies as a Research Fellow in the Psychobiology Laboratory at Harvard University and in the Department of Anatomy at the University of Cambridge. Although primarily studing the effects of drugs on the behaviour of animals, Dr Evenden also played an important role in the design and construction of the CANTAB neuropsychological test battery. In 1987 he moved to the pharmaceutical industry, working first at the MSD Neuroscience Research Center, and in 1989 moving to AB Astra, in Södertälje, Sweden. In 1999, Dr Evenden moved to the USA to assist in building up Astra’s and then AstraZeneca’s neuroscience research in the USA, where he served as Associate Director for Behavioural Pharmacology. Dr Evenden also acted as project leader for multidisciplinary drug discovery projects, as well as having a long involvement in early stage development projects in the areas of depression and cognition. In 2008 he left AstraZeneca and founded WiltonLogic, to apply his experience in translational neuroscience to developing new methods for studying impulsivity and decision making in humans and animals.